Onderneming ASEP Medical Holdings Inc. OTC Markets
Aandelen
SEPSF
CA04368A1057
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,05 USD | -62,51% | -.--% | -71,70% |
Vakgebied
Aantal werknemers: 7
Verkoop per activiteit
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Life Sciences and Medical Diagnostics
100,0
%
| 0 | nan % | 0 | 100,0 % | - |
Verkoop per regio
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Canada
100,0
%
| 0 | nan % | 0 | 100,0 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Robert Hancock
CEO | Chief Executive Officer | 75 | 20-01-21 |
Director of Finance/CFO | 68 | 01-10-22 | |
Rob Stenstrom
CTO | Chief Tech/Sci/R&D Officer | - | 24-02-23 |
Evan Haney
CTO | Chief Tech/Sci/R&D Officer | 42 | 09-11-21 |
Timothy Murphy
COO | Chief Operating Officer | 53 | 09-11-21 |
Fadia Saad
PRN | Corporate Officer/Principal | 61 | 09-11-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Robert Hancock
CEO | Chief Executive Officer | 75 | 20-01-21 |
Derrold Norgaard
BRD | Director/Board Member | 62 | 09-11-21 |
Timothy Murphy
COO | Chief Operating Officer | 53 | 09-11-21 |
Richard Heinzl
BRD | Director/Board Member | - | 29-09-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 76 059 147 | 73 681 350 ( 96,87 %) | 0 | 96,87 % |
Bedrijfsgegevens
ASEP Medical Holdings, Inc.
730 View Street Suite 420
V8W 3Y7, Victoria
+778-600-0509
http://asepmedical.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+38,66% | 52,85 mld. | |
-7,81% | 38,87 mld. | |
+35,51% | 38,24 mld. | |
-10,77% | 26,79 mld. | |
+11,77% | 26,16 mld. | |
-17,82% | 19,9 mld. | |
+35,09% | 13,18 mld. | |
+29,17% | 12,24 mld. | |
-3,05% | 11,79 mld. |
- Beurs
- Aandelen
- Koers ASEP
- Koers SEPSF
- Onderneming ASEP Medical Holdings Inc.